ArticleCancer science2008

Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor.

Toshirou Nishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.